Detalhe da pesquisa
1.
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
Br J Haematol
; 178(4): 547-560, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28466536
2.
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Oncologist
; 21(1): 33-9, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26670666
3.
Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study.
Am J Hematol
; 90(4): 314-9, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25557740
4.
Early progression and transformation of a splenic diffuse red pulp small B-cell lymphoma with NOTCH1, ARID2, CREBBP, and TNFRSF14 gene mutations.
Leuk Res Rep
; 20: 100384, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37664441
5.
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
Blood Rev
; 38: 100572, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31229334
6.
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
Clin Cancer Res
; 10(18 Pt 1): 6086-93, 2004 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15447994
7.
Epidermolysis bullosa acquisita and multiple myeloma.
J Am Acad Dermatol
; 47(6): 943-6, 2002 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-12451384